The present invention relates generally to medical devices, and in particular catheters with electrodes, and further relates to, but not exclusively, catheters suitable for use to induce irreversible electroporation (IRE) of cardiac tissues.
Cardiac arrhythmias, such as atrial fibrillation (AF), occur when regions of cardiac tissue abnormally conduct electric signals to adjacent tissue. This disrupts the normal cardiac cycle and causes asynchronous rhythm. Certain procedures exist for treating arrhythmia, including surgically disrupting the origin of the signals causing the arrhythmia and disrupting the conducting pathway for such signals. By selectively ablating cardiac tissue by application of energy via a catheter, it is sometimes possible to cease or modify the propagation of unwanted electrical signals from one portion of the heart to another.
Many current ablation approaches in the art tend to utilize radiofrequency (RF) electrical energy to heat tissue. RF ablation can have certain rare drawbacks due to operator's skill, such as heightened risk of thermal cell injury which can lead to tissue charring, burning, steam pop, phrenic nerve palsy, pulmonary vein stenosis, and esophageal fistula. Cryoablation is an alternative approach to RF ablation that generally reduces thermal risks associated with RF ablation but may present tissue damage due to the very low temperature nature of such devices. Maneuvering cryoablation devices and selectively applying cryoablation, however, is generally more challenging compared to RF ablation; therefore cryoablation is not viable in certain anatomical geometries which may be reached by electrical ablation devices.
Some ablation approaches use irreversible electroporation (IRE) to ablate cardiac tissue using nonthermal ablation methods. IRE delivers short pulses of high voltage to tissues and generates an unrecoverable permeabilization of cell membranes. Delivery of IRE energy to tissues using multi-electrode catheters was previously proposed in the patent literature. Examples of systems and devices configured for IRE ablation are disclosed in U.S. Patent Pub. No. 2021/0169550A1, 2021/0169567A1, 2021/0169568A1, 2021/0161592A1, 2021/0196372A1, 2021/0177503A1, and 2021/0186604A1, each of which are incorporated herein by reference and attached in the appendix to priority application U.S. 63/301,128.
Regions of cardiac tissue can be mapped by a catheter to identify the abnormal electrical signals. The same or different catheter can be used to perform ablation. Some example catheters include a number of spines with electrodes positioned thereon. The electrodes are generally attached to the spines and secured in place by soldering, welding, or using an adhesive. Furthermore, multiple linear spines are generally assembled together by attaching both ends of the linear spines to a tubular shaft (e.g., a pusher tube) to form a spherical basket. Due to the small size of the spines and the electrodes, however, adhering the electrodes to the spines and then forming a spherical basket from the multiple linear spines can be a difficult task, increasing the manufacturing time and cost and the chances that the electrode fails due to an improper bond or misalignment. What is needed, therefore, are devices and methods of forming an improved basket assembly that can help to reduce the time required for manufacturing the basket assembly and alternative basket assembly geometries in general.
Various embodiments of a medical probe and related methods are described and illustrated. There is provided, in accordance with an example of the disclosed technology, a medical probe including a tubular shaft and an expandable basket assembly. The tubular shaft can have a proximal end and a distal end. The tubular shaft extends along a longitudinal axis. The expandable basket assembly can be positioned proximate the distal end of the tubular shaft. The basket assembly can include a structure that includes spine sections and a central spine intersection, a loop retention hub, and one or more electrodes. The central spine intersection can be positioned on the longitudinal axis at a distal end of the basket assembly. Each spine section can have at least one end connected to the distal end of the tubular shaft. The loop retention hub can include a first portion and a second portion configured to mate with each other to retain a distal portion of each of the spine sections at the central spine intersection. The electrode(s) can be coupled to each of the spine sections. Each electrode can define a lumen through the electrode so that a spine section extends through the lumen of each of the one or more electrodes.
The disclosed technology can include a medical probe, comprising a tubular shaft including a proximal end and a distal end and an expandable basket assembly proximate the distal end of the tubular shaft. The basket assembly can include a plurality of spines, a loop retention hub, and one or more electrodes. The plurality of spines can each have a distal end comprising a stopper extending therefrom and a proximal end connected to the distal end of the tubular shaft. The spines can be configured to bow radially from the longitudinal axis. The loop retention hub can secure the distal ends of the plurality of spines such that the stoppers are configured to rotate with respect to the loop retention hub to allow the spines to bow radially from the longitudinal axis. The one or more electrodes can couple to each of the spines. Each electrode can define a lumen through the electrode so that a spine section extends through the lumen of each of the one or more electrodes.
The disclosed technology can include an example method of constructing a medical probe. The method can include clamping a first portion and a second portion of a loop retention hub over distal portions of a plurality of spine sections; coupling one or more electrodes to each of the spine sections; connecting at least one end of each of the spine sections to the distal end of a tubular shaft such that the plurality of spines extend along a longitudinal axis; and configuring the plurality of spine sections to extend radially outward from the longitudinal axis to define a basket shape. Each electrode can define a lumen through the electrode so that a spine section extends through the lumen of each of the one or more electrodes.
The following detailed description should be read with reference to the drawings, in which like elements in different drawings are identically numbered. The drawings, which are not necessarily to scale, depict selected embodiments and are not intended to limit the scope of the invention. The detailed description illustrates by way of example, not by way of limitation, the principles of the invention. This description will clearly enable one skilled in the art to make and use the invention, and describes several embodiments, adaptations, variations, alternatives and uses of the invention, including what is presently believed to be the best mode of carrying out the invention.
As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values ±20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 110%.
As used herein, the terms “patient,” “host,” “user,” and “subject” refer to any human or animal subject and are not intended to limit the systems or methods to human use, although use of the subject invention in a human patient represents a preferred embodiment. In addition, vasculature of a “patient,” “host,” “user,” and “subject” can be vasculature of a human or any animal. It should be appreciated that an animal can be a variety of any applicable type, including, but not limited thereto, mammal, veterinarian animal, livestock animal or pet type animal, etc. As an example, the animal can be a laboratory animal specifically selected to have certain characteristics similar to a human (e.g., rat, dog, pig, monkey, or the like). It should be appreciated that the subject can be any applicable human patient, for example. As well, the term “proximal” indicates a location closer to the operator or physician whereas “distal” indicates a location further away to the operator or physician.
As discussed herein, “operator” can include a doctor, surgeon, technician, scientist, or any other individual or delivery instrumentation associated with delivery of a multi-electrode catheter for the treatment of drug refractory atrial fibrillation to a subject.
As discussed herein, the term “ablate” or “ablation”, as it relates to the devices and corresponding systems of this disclosure, refers to components and structural features configured to reduce or prevent the generation of erratic cardiac signals in the cells by utilizing non-thermal energy, such as irreversible electroporation (IRE), referred throughout this disclosure interchangeably as pulsed electric field (PEF) and pulsed field ablation (PFA). Ablating or ablation as it relates to the devices and corresponding systems of this disclosure is used throughout this disclosure in reference to non-thermal ablation of cardiac tissue for certain conditions including, but not limited to, arrhythmias, atrial flutter ablation, pulmonary vein isolation, supraventricular tachycardia ablation, and ventricular tachycardia ablation. The term “ablate” or “ablation” also includes known methods, devices, and systems to achieve various forms of bodily tissue ablation as understood by a person skilled in the relevant art.
As discussed herein, the terms “bipolar” and “unipolar” when used to refer to ablation schemes describe ablation schemes which differ with respect to electrical current path and electric field distribution. “Bipolar” refers to ablation scheme utilizing a current path between two electrodes that are both positioned at a treatment site; current density and electric flux density is typically approximately equal at each of the two electrodes. “Unipolar” refers to ablation scheme utilizing a current path between two electrodes where one electrode including a high current density and high electric flux density is positioned at a treatment site, and a second electrode including comparatively lower current density and lower electric flux density is positioned remotely from the treatment site.
As discussed herein, the terms “biphasic pulse” and “monophasic pulse” refer to respective electrical signals. “Biphasic pulse” refers to an electrical signal including a positive-voltage phase pulse (referred to herein as “positive phase”) and a negative-voltage phase pulse (referred to herein as “negative phase”). “Monophasic pulse” refers to an electrical signal including only a positive or only a negative phase. Preferably, a system providing the biphasic pulse is configured to prevent application of a direct current voltage (DC) to a patient. For instance, the average voltage of the biphasic pulse can be zero volts with respect to ground or other common reference voltage. Additionally, or alternatively, the system can include a capacitor or other protective component. Where voltage amplitude of the biphasic and/or monophasic pulse is described herein, it is understood that the expressed voltage amplitude is an absolute value of the approximate peak amplitude of each of the positive-voltage phase and/or the negative-voltage phase. Each phase of the biphasic and monophasic pulse preferably has a square shape including an essentially constant voltage amplitude during a majority of the phase duration. Phases of the biphasic pulse are separated in time by an interphase delay. The interphase delay duration is preferably less than or approximately equal to the duration of a phase of the biphasic pulse. The interphase delay duration is more preferably about 25% of the duration of the phase of the biphasic pulse.
As discussed herein, the terms “tubular” and “tube” are to be construed broadly and are not limited to a structure that is a right cylinder or strictly circumferential in cross-section or of a uniform cross-section throughout its length. For example, the tubular structures are generally illustrated as a substantially right cylindrical structure. However, the tubular structures may have a tapered or curved outer surface without departing from the scope of the present disclosure.
The term “temperature rating”, as used herein, is defined as the maximum continuous temperature that a component can withstand during its lifetime without causing thermal damage, such as melting or thermal degradation (e.g., charring and crumbling) of the component.
The present disclosure is related to systems, methods or uses and devices which utilize end effectors including electrodes affixed to spines. Example systems, methods, and devices of the present disclosure may be particularly suited for IRE ablation of cardiac tissue to treat cardiac arrhythmias. Ablative energies are typically provided to cardiac tissue by a tip portion of a catheter which can deliver ablative energy alongside the tissue to be ablated. Some example catheters include three-dimensional structures at the tip portion and are configured to administer ablative energy from various electrodes positioned on the three-dimensional structures. Ablative procedures incorporating such example catheters can be visualized using fluoroscopy.
Ablation of cardiac tissue using application of a thermal technique, such as radio frequency (RF) energy and cryoablation, to correct a malfunctioning heart is a well-known procedure. Typically, to successfully ablate using a thermal technique, cardiac electropotentials need to be measured at various locations of the myocardium. In addition, temperature measurements during ablation provide data enabling the efficacy of the ablation. Typically, for an ablation procedure using a thermal technique, the electropotentials and the temperatures are measured before, during, and after the actual ablation.
RF approaches can have risks that can lead to tissue charring, burning, steam pop, phrenic nerve palsy, pulmonary vein stenosis, and esophageal fistula. Cryoablation is an alternative approach to RF ablation that can reduce some thermal risks associated with RF ablation. However maneuvering cryoablation devices and selectively applying cryoablation is generally more challenging compared to RF ablation; therefore cryoablation is not viable in certain anatomical geometries which may be reached by electrical ablation devices.
IRE as discussed in this disclosure is a non-thermal cell death technology that can be used for ablation of atrial arrhythmias. To ablate using IRE/PEF, biphasic voltage pulses are applied to disrupt cellular structures of myocardium. The biphasic pulses are non-sinusoidal and can be tuned to target cells based on electrophysiology of the cells. In contrast, to ablate using RF, a sinusoidal voltage waveform is applied to produce heat at the treatment area, indiscriminately heating all cells in the treatment area. IRE therefore has the capability to spare adjacent heat sensitive structures or tissues which would be of benefit in the reduction of possible complications known with ablation or isolation modalities. Additionally, or alternatively, monophasic pulses can be utilized.
Electroporation can be induced by applying a pulsed electric field across biological cells to cause reversable (temporary) or irreversible (permanent) creation of pores in the cell membrane. The cells have a transmembrane electrostatic potential that is increased above a resting potential upon application of the pulsed electric field. While the transmembrane electrostatic potential remains below a threshold potential, the electroporation is reversable, meaning the pores can close when the applied pulse electric field is removed, and the cells can self-repair and survive. If the transmembrane electrostatic potential increases beyond the threshold potential, the electroporation is irreversible, and the cells become permanently permeable. As a result, the cells die due to a loss of homeostasis and typically die by programmed cell death or apoptosis, which is believed to leave less scar tissue as compared to other ablation modalities. Generally, cells of differing types have differing threshold potential. For instance, heart cells have a threshold potential of approximately 500 V/cm, whereas for bone it is 3000 V/cm. These differences in threshold potential allow IRE to selectively target tissue based on threshold potential.
The solution of this disclosure includes systems and methods for applying electrical signals from catheter electrodes positioned in the vicinity of myocardial tissue, preferably by applying a pulsed electric field effective to induce electroporation in the myocardial tissue. The systems and methods can be effective to ablate targeted tissue by inducing irreversible electroporation. In some examples, the systems and methods can be effective to induce reversible electroporation as part of a diagnostic procedure. Reversible electroporation occurs when the electricity applied with the electrodes is below the electric field threshold of the target tissue allowing cells to repair.
Reversible electroporation does not kill the cells but allows a physician to see the effect of reversible electroporation on electrical activation signals in the vicinity of the target location. Example systems and methods for reversible electroporation is disclosed in U.S. Patent Publication 2021/0162210, each of which are incorporated herein by reference and attached in the appendix to priority application U.S. 63/301,128.
The pulsed electric field, and its effectiveness to induce reversible and/or irreversible electroporation, can be affected by physical parameters of the system and biphasic pulse parameters of the electrical signal. Physical parameters can include electrode contact area, electrode spacing, electrode geometry, etc. examples presented herein generally include physical parameters adapted to effectively induce reversible and/or irreversible electroporation. Biphasic pulse parameters of the electrical signal can include voltage amplitude, pulse duration, pulse interphase delay, inter-pulse delay, total application time, delivered energy, etc. In some examples, parameters of the electrical signal can be adjusted to induce both reversible and irreversible electroporation given the same physical parameters. Examples of various systems and methods of ablation including IRE are presented in U.S. Patent Publications 2021/0169550A1, 2021/0169567A1, 2021/0169568A1, 2021/0161592A1, 2021/0196372A1, 2021/0177503A1, and 2021/0186604A1, each of which are incorporated herein by reference and attached in the appendix to priority application U.S. 63/301,128.
To deliver pulsed field ablation (PFA) in an IRE (irreversible electroporation) procedure, electrodes should contact the tissue being ablated with a sufficiently large surface area. As described hereinbelow, the medical probe includes a tubular shaft including proximal and distal ends, and a basket assembly at the distal end of the tubular shaft. The basket assembly includes spine sections, a loop retention hub at a distal end of medical probe joining the spine sections, and at least one electrode on each spine, wherein the electrode(s) have a lumen through which a spine section extends.
Medical probe 22 includes a flexible insertion tube 30 and a handle 32 coupled to a proximal end of the tubular shaft. During a medical procedure, a medical professional 34 can insert the medical probe 22 through the vascular system of patient 28 so that a distal end 36 of the medical probe enters a body cavity such as a chamber of heart 26. Upon distal end 36 entering the chamber of heart 26, medical professional 34 can deploy a basket assembly 38 approximate a distal end 36 of the medical probe 22. Basket assembly 38 can include a plurality of electrodes 40 affixed to a plurality of spines 214, as described in the description referencing
The medical probe 22 can include a guide sheath and a therapeutic catheter, wherein the guide sheath includes the flexible insertion tube 30 and the handle 32, and the therapeutic catheter includes the basket assembly 38, electrodes 40, and a tubular shaft 84 (see
In the configuration shown in
As described hereinabove, in conjunction with tracking module 48, processor 46 may determine location coordinates of distal end 36 inside heart 26 based on impedances and/or currents measured between adhesive skin patches 44 and electrodes 40. Such a determination is typically after a calibration process relating the impedances or currents to known locations of the distal end has been performed. While embodiments presented herein describe electrodes 40 that are preferably configured to deliver IRE ablation energy to tissue in heart 26, configuring electrodes 40 to deliver any other type of ablation energy to tissue in any body cavity is considered to be within the spirit and scope of the present invention. Furthermore, although described in the context of being electrodes 40 that are configured to deliver IRE ablation energy to tissue in the heart 26, one skilled in the art will appreciate that the disclosed technology can be applicable to electrodes used for mapping and/or determining various characteristics of an organ or other part of the patient's 28 body.
Processor 46 may include real-time noise reduction circuitry 50 typically configured as a field programmable gate array (FPGA), followed by an analog-to-digital (A/D) signal conversion integrated circuit 52. The processor can be programmed to perform one or more algorithms and uses circuitry 50 and circuit 52 as well as features of modules to enable the medical professional 34 to perform the IRE ablation procedure.
Control console 24 also includes an input/output (I/O) communications interface 54 that enables control console 24 to transfer signals from, and/or transfer signals to electrodes 40 and adhesive skin patches 44. In the configuration shown in
IRE ablation module 56 is configured to generate IRE pulses including peak power in the range of tens of kilowatts. In some examples, the electrodes 40 are configured to deliver electrical pulses including a peak voltage of at least 700 volts (V). The medical system 20 performs IRE ablation by delivering IRE pulses to electrodes 40. Preferably, the medical system 20 delivers biphasic pulses between electrodes 40 on the spine. Additionally, or alternatively, the medical system 20 delivers monophasic pulses between at least one of the electrodes 40 and a skin patch.
Irrigation is sometimes utilized to reduce clot formation, stagnant blood flow or even reduce heat generated by ablation via the electrodes. As such, system 20 may supply irrigation fluid (e.g., a saline solution) to distal end 36 and to the electrodes 40 via a channel (not shown) in tubular shaft 84 (see
Based on signals received from electrodes 40 and/or adhesive skin patches 44, processor 46 can generate an electroanatomical map 62 that shows the location of distal end 36 in the patient's body. During the procedure, processor 46 can present map 62 to medical professional 34 on a display 64, and store data representing the electroanatomical map in a memory 66. Memory 66 may include any suitable volatile and/or non-volatile memory, such as random-access memory or a hard disk drive.
In some embodiments, medical professional 34 can manipulate map 62 using one or more input devices 68. In alternative embodiments, display 64 may include a touchscreen that can be configured to accept inputs from medical professional 34, in addition to presenting map 62.
Referring to
In embodiments described herein, one or more electrodes 40 positioned on spines 214 of basket assembly 38 can be configured to deliver ablation energy (RF and/or IRE) to tissue in heart 26. Additionally, or alternatively, the electrodes can also be used to determine the location of basket assembly 38 and/or to measure a physiological property such as local surface electrical potentials at respective locations on tissue in heart 26. The electrodes 40 can be biased such that a greater portion of the one or more electrodes 40 face outwardly from basket assembly 38 such that the one or more electrodes 40 deliver a greater amount of electrical energy outwardly away from the basket assembly 38 (i.e., toward the heart 26 tissue) than inwardly.
Examples of materials ideally suited for forming electrodes 40 include gold, platinum and palladium (and their respective alloys). These materials also have high thermal conductivity which allows the minimal heat generated on the tissue (i.e., by the ablation energy delivered to the tissue) to be conducted through the electrodes to the back side of the electrodes (i.e., the portions of the electrodes on the inner sides of the spines), and then to the blood pool in heart 26.
Referring collectively to
As described supra, control console 24 includes irrigation module 60 that delivers irrigation fluid to distal end 36 of flexible insertion tube 30. The multiple irrigation openings 98 can be angled to spray or otherwise disperse of the irrigation fluid to either a given electrode 40 or to tissue in heart 26. Since electrodes 40 do not include irrigation openings that deliver irrigation fluid, the configuration described hereinabove enables heat to be transferred from the tissue (i.e., during an ablation procedure) to the portion of the electrodes 40 on the inner side of the spines 214, and the electrodes 40 can be cooled by aiming the irrigation fluid, via irrigation openings 98, at the portion of the electrodes 40 on the inner side of the spines 214. Spine retention hub electrode 99 disposed at a distal end of retention hub 90 can be used in combination with electrodes 40 on the spines 214, or alternatively, can be used independently from electrodes 40 for reference mapping or ablation.
By including spines 214 configured to form various shapes when in the expanded form, basket assembly 38 can be configured to position the various electrodes 40 attached to spines 214 at various locations, with each location being nearer or farther from the distal end of tubular shaft 84. For example, electrode 40 attached to spine 214 illustrated in
Referring collectively to
In some examples, each electrode 40 can include electrically conductive material (e.g., gold, platinum and palladium (and their respective alloys)). Turning to
Each electrode 740A-740E can have an outer surface 774 facing outwardly from electrode 740 and an inner surface 776 facing inwardly toward electrode 740 where at least one lumen 770 is formed through electrode 740. The lumen 770 can be sized and configured to receive a spine 214 such that spine 214 can pass through electrode 740. Lumen 770 can be a symmetric opening through electrode 740A-740E and can be disposed offset with respect to a longitudinal axis L-L of the respective electrode. In other examples, lumen 770 can pass through electrode 740 in a generally transverse direction with respect to the longitudinal axis L-L of the respective electrode. Furthermore, lumen 770 can be positioned in electrode 740 nearer a bottom surface, nearer a top surface, or nearer a middle of electrode 740 depending on the particular configuration. In
In addition, as shown in
Alternatively, or in addition thereto, wires can pass through a wire lumen 773 as shown in example electrodes 740D and 740E in
As shown in
As illustrated in
Insulative jacket 906 can be configured to have a temperature rating between 150 and 200 degrees Centigrade so that the electrically insulative jacket 906 melts or degrades (e.g., chars and crumbles) during soldering of wire 900 to electrodes 40 (e.g., at a temperature of 300 degrees Centigrade) and therefore insulative jacket 906 of wire 900 does not need to be mechanically stripped. In other examples, insulative jacket 906 can have a temperature rating greater than 200 degrees Centigrade to prevent electrically insulating material 906 melting or degrading (e.g., charring and crumbling) during manufacture of medical probe 22 and/or during use. Insulative jacket 906 can be mechanically stripped from wire 900 prior to wires 900 being electrically connected to electrodes 40.
As will be appreciated by one skilled in the art, method 1000 can include any of the various features of the disclosed technology described herein and can be varied depending on the particular configuration. Thus, method 1000 should not be construed as limited to the particular steps and order of steps explicitly described herein. It is noted that while the preference for the exemplary embodiments of the medical probe is for IRE or PFA, it is within the scope of the present invention to also use the medical probe separately only for RF ablation (unipolar mode with an external grounding electrode or bipolar mode) or in combination with IRE and RF ablations sequentially (certain electrodes in IRE mode and other electrodes in RF mode) or simultaneously (some electrodes in IRE mode and other electrodes in RF mode).
The disclosed technology described herein can be further understood according to the following clauses:
Clause 1: A medical probe, comprising:
a tubular shaft including a proximal end and a distal end, the tubular shaft extending along a longitudinal axis; an expandable basket assembly proximate the distal end of the tubular shaft, the basket assembly comprising: a structure that includes a plurality of spine sections and a central spine intersection being positioned on the longitudinal axis at a distal end of the basket assembly, each spine section including at least one end connected to the distal end of the tubular shaft, a loop retention hub comprising a first portion and a second portion configured to mate with each other to retain a distal portion of each of the spine sections at the central spine intersection; and one or more electrodes coupled to each of the spine sections, each electrode defining a lumen through the electrode so that a spine section extends through the lumen of each of the one or more electrodes.
Clause 2: The medical probe according to Clause 1, wherein the loop retention hub further comprises a hinge between the first portion and the second portion.
Clause 3: The medical probe according to any one of Clauses 1-2, wherein the expandable basket assembly defines a spherical outer profile.
Clause 4: The medical probe according to any one of Clauses 1-2, wherein the expandable basket assembly defines an oblate-spheroid profile.
Clause 5: The medical probe according to any one of Clauses 1-4, further comprising a spine retention hub disposed proximate the distal end of the tubular shaft, the spine retention hub comprising a cylindrical member including a plurality of relief lands disposed on the outer surface of the cylindrical member to allow each spine section to be fitted into the relief land and retained therein, the spine retention hub further comprising at least one electrode disposed at a distal portion of the spine retention hub.
Clause 6: The medical probe according to Clause 5, wherein the plurality of spine sections comprises spine loops, each spine loop comprising a single unitary loop including a distal loop and two ends secured between the tubular shaft and in one of the relief lands of the spine retention hub.
Clause 7: The medical probe according to Clause 6, wherein the distal loops of each spine loop overlap within the loop retention hub.
Clause 8: The medical probe according to any one of Clauses 6-7, wherein the loop retention hub further comprises: two or more protrusions positioned on the first portion and/or the second portion; and two or more indentations positioned on the opposite portion of the first portion and the second portion, the indentations engaging the protrusions to clamp the first portion to the second portion.
Clause 9: The medical probe according to Clause 8, wherein the plurality of spine sections fit within paths formed between the two or more protrusions.
Clause 10: The medical probe according to any of Clauses 1-5, wherein the plurality of spine sections each comprise a stopper positioned at the distal end of the respective spine section, the stopper securing each spine section within the loop retention hub.
Clause 11: The medical probe according to Clause 10, wherein each stopper disposed between the first portion and the second portion of the loop retention hub, and wherein each stopper is configured to rotate longitudinally within the loop retention hub to allow radial expansion of the basket assembly.
Clause 12: The medical probe according to any one of Clauses 10-11, wherein the loop retention hub comprises a plurality of slots including a respective spine section of the plurality of spine sections extending therethrough such that rotation of each stopper results in longitudinal movement of the respective spine section through the respective slot.
Clause 13: The medical probe according to any one of Clauses 1-12, wherein each electrode comprises a wire relief adjacent the lumen to allow for one or more wires to extend adjacent to the lumen.
Clause 14: The medical probe according to any one of Clauses 1-13, wherein the electrode lumen is disposed symmetrically about a longitudinal axis of the electrode.
Clause 15: The medical probe according to any one of Clauses 1-13, wherein the electrode lumen is disposed offset with respect to a longitudinal axis of the electrode.
Clause 16: The medical probe according to any one of Clauses 1-15, wherein the one or more electrodes are configured to deliver electrical pulses for irreversible electroporation, the pulses including a peak voltage of at least 900 volts (V).
Clause 17: The medical probe according to any one of Clauses 1-16, further comprising irrigation openings disposed proximate the distal end of the tubular shaft, the irrigation openings configured to deliver an irrigation fluid to the one or more electrodes.
Clause 18: The medical probe according to any one of Clauses 1-17, further comprising a plurality of insulative sleeves each disposed over the respective given spine section and within the lumen of the respective electrode.
Clause 19: The medical probe according to any one of Clauses 1-17 further comprising a plurality of insulative sleeves, each insulative sleeve comprising a first lumen through which the respective given spine section extends and a second lumen through which an electrical wire extends, that the first and second lumens being distinct from each other, and each insulative sleeve extends within the lumen of the respective electrode.
Clause 20: The medical probe according to any one of Clauses 1-19, further comprising: a plurality of wires each electrically joined to a respective electrode of the one or more electrodes, wherein at least a portion of the wires of the plurality of the wires respectively comprises an electrically conductive core material comprising a first electrical conductivity, an electrically conductive cover material comprising a second electrical conductivity less than the first electrical conductivity, the electrically conductive cover material circumscribing the electrically conductive core material, and an insulative jacket circumscribing the electrically conductive cover material.
Clause 21: The medical probe according to any one of Clauses 1-20, further comprising: a plurality of wires each electrically joined to a respective electrode of the one or more electrodes, wherein at least a portion of the wires of the plurality of the wires respectively comprises a plurality of strands and an insulative jacket circumscribing the plurality of the strands, and wherein each strand of the plurality of strands respectively comprises an electrically conductive core material comprising a first electrical conductivity and an electrically conductive cover material comprising a second electrical conductivity less than the first electrical conductivity, the electrically conductive cover material circumscribing the electrically conductive core material.
Clause 22: The medical probe according to any one of Clauses 1-21, wherein the plurality of spine sections comprises nitinol.
Clause 23: The medical probe according to any one of Clauses 1-21, wherein the plurality of spine sections comprises metallic strands.
Clause 24: The medical probe according any one of Clauses 1-23 further comprising a central member disposed within the tubular shaft and moveable along the longitudinal axis, wherein each spine loop is moveable from an expanded configuration to a collapsed configuration when the central member moves along the longitudinal axis.
Clause 25: A medical probe, comprising: a tubular shaft including a proximal end and a distal end, the tubular shaft extending along a longitudinal axis; an expandable basket assembly proximate the distal end of the tubular shaft, the basket assembly comprising looped spine sections overlapping proximate a distal end of the medical probe, each looped spine section including two ends connected to the distal end of the tubular shaft, a loop retention hub comprising a first portion and a second portion clamped over the looped spine sections proximate the distal end of medical probe; and one or more electrodes coupled to each of the looped spine sections, each electrode defining a lumen through the electrode so that a spine section extends through the lumen of each of the one or more electrodes.
Clause 26: The medical probe according to Clause 25, wherein the loop retention hub further comprises two or more protrusions positioned on the first portion and two or more indentations positioned on the second portion, the indentations engaging the one or more protrusions of the first portion, and wherein the looped spine sections fit within paths formed between the two or more protrusions.
Clause 27: A medical probe, comprising: a tubular shaft including a proximal end and a distal end, the tubular shaft extending along a longitudinal axis; an expandable basket assembly proximate the distal end of the tubular shaft, the basket assembly comprising a plurality of spines each comprising a distal end comprising a stopper extending therefrom and a proximal end connected to the distal end of the tubular shaft, the spines being configured to bow radially from the longitudinal axis; a loop retention hub securing the distal ends of the plurality of spines such that the stoppers are configured to rotate with respect to the loop retention hub to allow the spines to bow radially from the longitudinal axis; and one or more electrodes coupled to each of the spine sections, each electrode defining a lumen through the electrode so that a spine section extends through the lumen of each of the one or more electrodes.
Clause 28: The medical probe according to Clause 27, wherein the loop retention hub comprises a first portion and a second portion clamped over the stoppers of the plurality of spines.
Clause 29: The medical probe according to any one of Clauses 27-28, wherein the loop retention hub comprises a plurality of slots including a respective spine of the plurality of spines extending therethrough such that rotation of each stopper results in longitudinal movement of the respective spine through the respective slot.
Clause 30: A method of constructing a medical probe, the method comprising: clamping a first portion and a second portion over distal portions of a plurality of spine sections; coupling one or more electrodes to each of the spine sections, each electrode defining a lumen through the electrode so that a spine section extends through the lumen of each of the one or more electrodes; connecting at least one end of each of the spine sections to the distal end of the tubular shaft such that the flexible insertion time and the plurality of spines extend along a longitudinal axis; and configuring the plurality of spine sections to extend radially outward from the longitudinal axis to define a basket shape.
Clause 31: The method of Clause 30, wherein clamping the first portion and the second portion over distal portions of the plurality of spine sections comprises bending a hinge between the first portion and the second portion.
Clause 32: The method of any one of Clauses 30-31, wherein the basket shape is approximately spherical.
Clause 33: The method of any one of Clauses 30-31, wherein the basket shape is approximately oblate-spheroid.
Clause 34: The method of any one of Clauses 30-33, further comprising: affixing a spine retention hub proximate the distal end of the tubular shaft, the spine retention hub comprising a cylindrical member including a plurality of relief lands disposed on the outer surface of the cylindrical member, the spine retention hub further comprising at least one electrode disposed at a distal portion of the spine retention hub; and fitting each spine section into a relief land of the plurality of relief lands.
Clause 35: The method of any one of Clauses 30-34, wherein the plurality of spine sections comprises spine loops, each spine loop comprising a single unitary loop including a distal loop, the method further comprising: securing two ends of each of the spine loops in the tubular shaft.
Clause 36: The method of any one of Clauses 30-35, further comprising: overlapping the distal portions of each spine section within the loop retention hub.
Clause 37: The method of any one of Clauses 30-36, further comprising: engaging two or more protrusions on the first portion and/or the second portion to two or more indentations on an opposite portion of the first portion and the second portion.
Clause 38: The method of Clause 37, further comprising: fitting the plurality of spine sections within paths formed between the two or more protrusions.
Clause 39: The method of any one of Clauses 30-34, wherein the plurality of spine sections each comprise a stopper positioned at the distal end of the respective spine section, the method further comprising: securing the stopper of each spine section within the loop retention hub.
Clause 40: The method of Clause 39, further comprising: positioning each stopper between the first portion and the second portion of the loop retention hub; and configuring each stopper to rotate longitudinally within the loop retention hub to allow radial expansion of the basket assembly.
Clause 41: The method of any one of Clauses 39-40, wherein the loop retention hub comprises a plurality of slots including a respective spine section of the plurality of spine sections extending therethrough such that rotation of each stopper results in longitudinal movement of the respective spine section through the respective slot.
Clause 42: The method of any one of Clauses 30-41, further comprising: extending one or more wires through a wire relief adjacent the lumen of the electrode such that the one or more wires extend adjacent to the lumen.
Clause 43: The method of any one of Clauses 30-42, wherein the electrode lumen is disposed symmetrically about a longitudinal axis of the electrode.
Clause 44: The method of any one of Clauses 30-43, wherein the electrode lumen is disposed offset with respect to a longitudinal axis of the electrode.
Clause 45: The method of any one of Clauses 30-44, further comprising: positioning a central member within the tubular shaft such that the central member is moveable along the longitudinal axis and such that each spine loop is moveable from an expanded configuration to a collapsed configuration when the central member moves along the longitudinal axis.
The embodiments described above are cited by way of example, and the present invention is not limited by what has been particularly shown and described hereinabove. Rather, the scope of the invention includes both combinations and sub combinations of the various features described and illustrated hereinabove, as well as variations and modifications thereof which would occur to persons skilled in the art upon reading the foregoing description and which are not disclosed in the prior art.
This application claims the benefit of priority under 35 U.S.C. § 119 to prior filed U.S. Provisional Application No. 63/301,128, filed on Jan. 20, 2022, the entire contents of which is incorporated herein by reference in its entirety as if fully set forth below.
Number | Date | Country | |
---|---|---|---|
63301128 | Jan 2022 | US |